This is a long term hold now. I will hold for a year no matter what. Last purchase was day before yesterday and I intend to add some here. Looks like $20 or so is the best and am getting bored watching it so I am buying right now.
Adam was sitting yesterday from 9.00 am to 4.30 pm in Vvus FDA Panel. At 4.10 he says approval chances are 50% at 4.30pm voting took place and 20:2 favouring approval for Qnexa.
What an Idiot Adam, can't sense after 8hrs witness the proceedings, hear all speakers and still was reporting 50% chances
JPMorgan lines up a $45 price target on Vivus (VVUS) in the wake of the company's FDA panel recommendation for approval for its weight-loss drug. Analysts with the firm keep an Overweight rating in place, saying "we would still be buyers here given the magnitude of the vote."